$EQ
Equillium, Inc.

2019 Q1 Form 10-K Financial Statement

#000156459019009580 Filed on March 27, 2019

View on sec.gov

Income Statement

Concept 2019 Q1 2018 2017 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.590M $3.670M $160.0K
YoY Change 865.79%
% of Gross Profit
Research & Development $3.759M $4.943M $480.0K
YoY Change 466.97% 271.65%
% of Gross Profit
Depreciation & Amortization $10.00K $6.000K $0.00
YoY Change
% of Gross Profit
Operating Expenses $6.348M $8.615M -$639.8K
YoY Change 512.15% 403.8%
Operating Profit -$6.348M -$8.615M
YoY Change 512.15%
Interest Expense $400.0K -$4.630M -$470.0K
YoY Change 741.82%
% of Operating Profit
Other Income/Expense, Net $398.0K -$4.635M
YoY Change -173.7%
Pretax Income -$5.950M -$13.25M -$1.110M
YoY Change 486.28%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$5.950M -$13.25M -$1.106M
YoY Change 277.3% 486.28%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$342.3K -$1.087M -$66.27K
COMMON SHARES
Basic Shares Outstanding 17.38M
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q1 2018 2017 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $61.61M $65.91M $7.104M
YoY Change 828.31%
Cash & Equivalents $21.39M $28.51M $7.104M
Short-Term Investments $40.21M $37.40M $0.00
Other Short-Term Assets $1.000M $1.190M $0.00
YoY Change 2280.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $62.63M $67.10M $7.149M
YoY Change 838.46%
LONG-TERM ASSETS
Property, Plant & Equipment $83.00K $60.00K $2.077K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $15.00K
YoY Change
Total Long-Term Assets $98.00K $60.00K $2.077K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $62.63M $67.10M $7.149M
Total Long-Term Assets $98.00K $60.00K $2.077K
Total Assets $62.73M $67.16M $7.151M
YoY Change 839.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.588M $1.120M $243.7K
YoY Change 366.67%
Accrued Expenses $1.464M $910.0K $325.1K
YoY Change 175.76%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.052M $2.030M $568.8K
YoY Change 256.14%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $8.100M
YoY Change -100.0%
Other Long-Term Liabilities $200.0K $200.0K $800.0K
YoY Change -74.36%
Total Long-Term Liabilities $181.0K $200.0K $8.900M
YoY Change -97.74%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.052M $2.030M $568.8K
Total Long-Term Liabilities $181.0K $200.0K $8.900M
Total Liabilities $3.233M $2.230M $9.404M
YoY Change -76.28%
SHAREHOLDERS EQUITY
Retained Earnings -$21.46M -$2.262M
YoY Change
Common Stock $80.91M $9.789K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $59.49M $64.94M -$2.252M
YoY Change
Total Liabilities & Shareholders Equity $62.73M $67.16M $7.151M
YoY Change 839.3%

Cashflow Statement

Concept 2019 Q1 2018 2017 Q4
OPERATING ACTIVITIES
Net Income -$5.950M -$13.25M -$1.106M
YoY Change 277.3% 486.28%
Depreciation, Depletion And Amortization $10.00K $6.000K $0.00
YoY Change
Cash From Operating Activities -$4.464M -$7.526M -$390.0K
YoY Change 402.14% 1040.3%
INVESTING ACTIVITIES
Capital Expenditures $11.00K $35.00K $0.00
YoY Change 120.0%
Acquisitions
YoY Change
Other Investing Activities -$2.640M -$37.40M
YoY Change
Cash From Investing Activities -$2.651M -$37.43M $0.00
YoY Change 52920.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 66.37M 6.770M
YoY Change 754.13%
NET CHANGE
Cash From Operating Activities -4.464M -7.526M -390.0K
Cash From Investing Activities -2.651M -37.43M 0.000
Cash From Financing Activities 66.37M 6.770M
Net Change In Cash -7.115M 21.40M 6.380M
YoY Change 695.86% 201.05%
FREE CASH FLOW
Cash From Operating Activities -$4.464M -$7.526M -$390.0K
Capital Expenditures $11.00K $35.00K $0.00
Free Cash Flow -$4.475M -$7.561M -$390.0K
YoY Change 400.56% 1045.61%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28508534
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7103553
CY2018Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
37404750
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1185844
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
45813
CY2018Q4 us-gaap Assets Current
AssetsCurrent
67099128
CY2017Q4 us-gaap Assets Current
AssetsCurrent
7149366
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
63515
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2077
CY2018Q4 us-gaap Assets
Assets
67162643
CY2017Q4 us-gaap Assets
Assets
7151443
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1119150
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
243741
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
908827
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
325079
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2027977
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
568820
CY2017Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
6994847
CY2017Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
1064019
CY2017Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
775842
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
199530
CY2018Q4 us-gaap Liabilities
Liabilities
2227507
CY2017Q4 us-gaap Liabilities
Liabilities
9403528
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
789
us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
18849
CY2018 dei Entity Small Business
EntitySmallBusiness
true
CY2018 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2018 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2018 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2018 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2018 dei Entity Shell Company
EntityShellCompany
false
CY2019Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
17376236
CY2018Q2 dei Entity Public Float
EntityPublicFloat
0
CY2018 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2018 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2018 dei Trading Symbol
TradingSymbol
EQ
CY2018 dei Entity Registrant Name
EntityRegistrantName
EQUILLIUM, INC.
CY2018 dei Entity Central Index Key
EntityCentralIndexKey
0001746466
CY2018 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2018 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1333721
CY2018 us-gaap Operating Expenses
OperatingExpenses
8615587
us-gaap Operating Income Loss
OperatingIncomeLoss
-1712049
CY2018 us-gaap Interest Expense Debt
InterestExpenseDebt
2557510
us-gaap Interest Expense Debt
InterestExpenseDebt
379385
CY2018 us-gaap Investment Income Interest
InvestmentIncomeInterest
339620
CY2018 eq Change In Fair Value Adjustment Of Anti Dilution Right
ChangeInFairValueAdjustmentOfAntiDilutionRight
2416998
eq Change In Fair Value Adjustment Of Anti Dilution Right
ChangeInFairValueAdjustmentOfAntiDilutionRight
170440
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4634888
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-8615587
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-549825
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-13250475
us-gaap Net Income Loss
NetIncomeLoss
-2261874
CY2018 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
5279
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13245196
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2261874
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.09
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.22
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
12190245
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7151443
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
43100000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17376236
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10708074
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17376236
CY2018 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-2557510
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-379385
us-gaap Other Research And Development Expense
OtherResearchAndDevelopmentExpense
615091
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1140031
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
45813
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
842722
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
243740
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10708074
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
124
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
80441417
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
9665
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
5279
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15512349
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2261874
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
64935136
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
-2252085
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
67162643
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
10106760
CY2017Q1 us-gaap Stockholders Equity
StockholdersEquity
0
CY2018 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
44
CY2018 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
12303760
CY2018 us-gaap Adjustments To Additional Paid In Capital Stock Split
AdjustmentsToAdditionalPaidInCapitalStockSplit
197
CY2018 eq Vesting Of Restricted Stock Liability
VestingOfRestrictedStockLiability
18598
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
441914
CY2018 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
2123106
CY2018 us-gaap Profit Loss
ProfitLoss
-13250475
us-gaap Profit Loss
ProfitLoss
-2261874
CY2018 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6102
us-gaap Depreciation And Amortization
DepreciationAndAmortization
122
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
441914
CY2018 us-gaap Straight Line Rent
StraightLineRent
-696
CY2018 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
598314
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
236708
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7526250
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-662201
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
34858
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2199
CY2018 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
37399471
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-37434329
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2199
CY2018 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
64475457
CY2018 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1599012
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
6767853
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1000000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
100
CY2018 eq Proceeds From Exercise Of Stock Options Including Early Exercise
ProceedsFromExerciseOfStockOptionsIncludingEarlyExercise
291091
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
66365560
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7767953
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
21404981
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7103553
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7103553
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28508534
us-gaap Stock Issued1
StockIssued1
9689
CY2018 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
32682
CY2018 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
12303760
CY2018 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of the Company&#8217;s financial statements requires the Company to make estimates and assumptions that impact the reported amounts of assets, liabilities and expenses and the disclosure of contingent assets and liabilities in the financial statements and accompanying notes. Management evaluates its estimates on an ongoing basis. Although estimates are based on the Company&#8217;s historical experience, knowledge of current events, and actions it may undertake in the future, actual results may ultimately materially differ from these estimates and assumptions. </p>
CY2018 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Concentration of Credit Risk and Off-Balance Sheet Risk</p> <p style="margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments which potentially subject the Company to significant concentration of credit risk consist of cash and cash equivalents and short-term investments. The Company maintains deposits in federally insured financial institutions in excess of federally insured limits. The Company has not experienced any losses in such accounts, and management believes that the Company is not exposed to significant credit risk due to the financial position of the depository institutions in which those deposits are held. The Company&#8217;s investment policy includes guidelines for the quality of the related institutions and financial instruments and defines allowable investments that the Company may invest in, which the Company believes minimizes the exposure to concentration of credit risk.</p>
CY2018 us-gaap Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
Federal net operating losses generated in 2018 carryover indefinitely and may generally be used to offset up to 80% of future taxable income
CY2018Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
65900000
CY2018 us-gaap Dividends
Dividends
0
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
420481
CY2018Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
37404750
CY2018Q4 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2018Q4 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2018 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
CY2018 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2018Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
37399471
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
5279
CY2017Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
0
CY2018 us-gaap Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities
0
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6224
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
122
CY2018 us-gaap Depreciation
Depreciation
6102
us-gaap Depreciation
Depreciation
122
CY2018 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
0
us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
0
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
559541
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
15548
CY2018Q4 eq Accrued Clinical Studies
AccruedClinicalStudies
244506
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
632
CY2017Q4 eq Accrued Preclinical Studies
AccruedPreclinicalStudies
36000
CY2017Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
184527
CY2017Q4 us-gaap Interest Payable Current
InterestPayableCurrent
88372
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.79
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
46080
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
89328
CY2018 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
-1036530
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
-1125078
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
-2225880
CY2018Q4 us-gaap Operating Expenses
OperatingExpenses
-4228099
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-1576796
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-1765363
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-4916423
us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.0878
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
291091
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
3345710
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
441914
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0283
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.8829
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M28D
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2018 eq Dividends Paid On Common Stock
DividendsPaidOnCommonStock
0
CY2018Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
2126877
CY2017Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
1189773
CY2018 eq Non Cancelable Operating Lease Expiration
NonCancelableOperatingLeaseExpiration
2022-02
CY2018 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
49255
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
0
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
57522
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
58914
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
59192
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
9865
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
185493
CY2018 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
0
CY2017 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
0
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.3400
CY2018 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0000
us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0000
CY2018 eq Effective Income Tax Rate Reconciliation Permanent Items
EffectiveIncomeTaxRateReconciliationPermanentItems
-0.0976
eq Effective Income Tax Rate Reconciliation Permanent Items
EffectiveIncomeTaxRateReconciliationPermanentItems
-0.1092
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.0000
CY2018 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.0168
us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.0041
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.1292
us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.1471
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.00
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.00
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2268242
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
248222
CY2018Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
333527
CY2017Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
43162
CY2018Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
184847
CY2018Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
224534
CY2017Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
198290
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
3011150
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
489674
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3010878
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
489585
CY2018Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
272
CY2017Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
89
CY2018Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
272
CY2017Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
89
CY2018Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
272
CY2017Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
89
CY2018Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2017Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2018 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
2521293
CY2018 eq Operating Loss Carryforwards Expiration Year
OperatingLossCarryforwardsExpirationYear
2037
CY2018Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
7127000
CY2018 eq Tax Credit Carryforward Expiration Year
TaxCreditCarryforwardExpirationYear
2037
CY2018 eq Cumulative Change In Ownership Percentage
CumulativeChangeInOwnershipPercentage
0.50
CY2018 eq Cumulative Change In Ownership Period
CumulativeChangeInOwnershipPeriod
P3Y
us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-198687
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
18849
CY2018 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
11310
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
81789
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
-4991893
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.15
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.16
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.44
CY2018Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.31
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
-67195
CY2017Q2 us-gaap Operating Expenses
OperatingExpenses
-921341
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
-83711
CY2017Q4 us-gaap Operating Expenses
OperatingExpenses
-639801
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-67195
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-947297
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-141025
CY2017Q4 us-gaap Net Income Loss
NetIncomeLoss
-1106357
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.10
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2017Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.10

Files In Submission

Name View Source Status
0001564590-19-009580-index-headers.html Edgar Link pending
0001564590-19-009580-index.html Edgar Link pending
0001564590-19-009580.txt Edgar Link pending
0001564590-19-009580-xbrl.zip Edgar Link pending
eq-10k_20181231.htm Edgar Link pending
eq-20181231.xml Edgar Link completed
eq-20181231.xsd Edgar Link pending
eq-20181231_cal.xml Edgar Link unprocessable
eq-20181231_def.xml Edgar Link unprocessable
eq-20181231_lab.xml Edgar Link unprocessable
eq-20181231_pre.xml Edgar Link unprocessable
eq-ex211_463.htm Edgar Link pending
eq-ex231_899.htm Edgar Link pending
eq-ex311_142.htm Edgar Link pending
eq-ex312_141.htm Edgar Link pending
eq-ex321_140.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gxgrfrirwhvy000001.jpg Edgar Link pending
gxgrfrirwhvy000002.jpg Edgar Link pending
gxgrfrirwhvy000003.jpg Edgar Link pending
gxgrfrirwhvy000004.jpg Edgar Link pending
gxgrfrirwhvy000005.jpg Edgar Link pending
gxgrfrirwhvy000006.jpg Edgar Link pending
gxgrfrirwhvy000007.jpg Edgar Link pending
gxgrfrirwhvy000008.jpg Edgar Link pending
gxgrfrirwhvy000009.jpg Edgar Link pending
gxgrfrirwhvy000010.jpg Edgar Link pending
gxgrfrirwhvy000011.jpg Edgar Link pending
gxgrfrirwhvy000012.jpg Edgar Link pending
gxgrfrirwhvy000013.jpg Edgar Link pending
gxgrfrirwhvy000014.jpg Edgar Link pending
gxgrfrirwhvy000015.jpg Edgar Link pending
gxgrfrirwhvy000016.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending